标题
Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
作者
关键词
Biomarkers, Fatty liver, Biopsy, Diagnostic medicine, Fibrosis, Liver diseases, Steatosis, Fibroblast growth factor
出版物
PLoS One
Volume 10, Issue 6, Pages e0131664
出版商
Public Library of Science (PLoS)
发表日期
2015-06-30
DOI
10.1371/journal.pone.0131664
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
- (2013) Amedeo Lonardo et al. CURRENT PHARMACEUTICAL DESIGN
- Antioxidant Therapy and Drugs Interfering with Lipid Metabolism: Could They Be Effective in NAFLD Patients?
- (2013) Giovanni Musso et al. CURRENT PHARMACEUTICAL DESIGN
- NAFLD in Asia—as common and important as in the West
- (2013) Geoffrey C. Farrell et al. Nature Reviews Gastroenterology & Hepatology
- Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk
- (2012) Y. Yilmaz ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis
- (2012) Yusuf Yilmaz et al. CLINICA CHIMICA ACTA
- IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
- (2012) Jan Petrasek et al. JOURNAL OF CLINICAL INVESTIGATION
- Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
- (2012) Jiayun Shen et al. JOURNAL OF HEPATOLOGY
- Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis
- (2011) Yusuf Yilmaz et al. CLINICA CHIMICA ACTA
- Endpoints and clinical trial design for nonalcoholic steatohepatitis
- (2011) Arun J. Sanyal et al. HEPATOLOGY
- Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans
- (2011) Jussi Pihlajamäki et al. JOURNAL OF HEPATOLOGY
- Serum Cytokeratin 18 M30 Antigen Level and Its Correlation with Nutritional Parameters in Middle-Aged Japanese Males with Nonalcoholic Fatty Liver Disease (NAFLD)
- (2011) Mayumi TABUCHI et al. JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
- Pathophysiological Role of Pigment Epithelium-Derived Factor (PEDF) in Hepatic Disorders
- (2010) S.-I. Yamagishi et al. CURRENT MEDICINAL CHEMISTRY
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
- (2010) V. W.-S. Wong et al. GUT
- Plasma Level of Pigment Epithelium-Derived Factor Is Independently Associated with the Development of the Metabolic Syndrome in Chinese Men: A 10-Year Prospective Study
- (2010) Cheng Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- An apoptosis panel for nonalcoholic steatohepatitis diagnosis
- (2010) Tarek I. Abu-Rajab Tamimi et al. JOURNAL OF HEPATOLOGY
- Serum Levels of CK18 M30 and Leptin Are Useful Predictors of Steatohepatitis and Fibrosis in Paediatric NAFLD
- (2010) Emer Fitzpatrick et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease
- (2010) Yusuf Yilmaz et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
- (2009) Stergios Polyzos et al. CURRENT MOLECULAR MEDICINE
- Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease
- (2009) Lauren N. Bell et al. HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Recent advances in nonalcholic fatty liver disease
- (2008) Victoria Greenfield et al. CURRENT OPINION IN GASTROENTEROLOGY
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- Cytokeratin 18, a Marker of Cell Death, Is Increased in Children With Suspected Nonalcoholic Fatty Liver Disease
- (2008) Miriam B Vos et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
- (2008) Zobair M. Younossi et al. OBESITY SURGERY
- Current and Emerging Therapies in Nonalcoholic Fatty Liver Disease
- (2008) Maryam Kashi et al. SEMINARS IN LIVER DISEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started